06 March 2013

MicroVention Opens New Manufacturing Facility in Costa Rica

Tustin, Calif. – 06 March 2013 - MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, has opened its new manufacturing facility in San Jose, Costa Rica. The new plant represents MicroVention's first manufacturing facility outside the United States and the first Neurovascular manufacturing facility in Costa Rica, which is located at the Coyol Free Zone in the Alajuela region of Costa Rica

"MicroVention will be the first company specializing in the neurovascular segment, and we are excited to welcome MicroVention to the Alajuela region," commented Gabriela Llobet, Director General, Costa Rican Investment Promotion Agency (CINDE). 

This new facility will support the growth and expansion of products offered under the MicroVention and Terumo brand and the Company has hired approximately 150 Associates with plans to expand in the coming months/years. The new plant is located just outside of San Jose, the nation's capital (the size of the new facility is 7,500 M2/80,000 sq. ft. and will encompass a 2,300 M2 clean room/25,000 sq. ft.). 

"We are very excited about the initiation of our first manufacturing facility in Costa Rica and commemorating the opening with many of our new partners celebrating with us. Our intent was to create a world-class facility extension of our corporate manufacturing plant in Tustin, CA, USA, and we have achieved that goal today," said Richard Cappetta, President and Chief Executive Officer of MicroVention, Inc. 

Approximately 12,000 people currently work in the Life Sciences Sector in Costa Rica with 41 medical device companies producing orthopedic, cardiovascular, women's health devices, and medical supplies. MicroVention will be the first company specializing in the neurovascular segment in Costa Rica. MicroVention has been recruiting its first employees, specifically in the areas of Engineering, Quality, Production and Administration. 

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. 

MicroVention, Inc. is a U.S. subsidiary of Terumo Corporation with its corporate headquarters in Tustin, California, and manufacturing and administrative facilities in Santa Ana and Aliso Viejo, California, and San Jose, Costa Rica. MicroVention is a developer, manufacturer and marketer of innovative neuroendovascular technologies for the treatment of vascular diseases in small vessels. MicroVention products are sold throughout the world in more than 60 countries. 

Source: MicroVention